Faslodex FDA Approved Drugs
FASLODEX [FulvestrantC32H47F5O3S]
RX
- 50mg/ml (intramuscular injectable)
AstrazenecaApr 25, 2002
- Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
- Treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbococlib in women with disease progression after endocrine therapy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.